Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.3285 EUR -3.38% Market Closed
Market Cap: 35.2m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gensight Biologics SA
Cash & Cash Equivalents Peer Comparison

Comparables:
VLA
G
GNFT
IVA
ALERS
OSE

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Cash & Cash Equivalents
€6.9m
CAGR 3-Years
-50%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Cash & Cash Equivalents
€131.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genfit SA
PAR:GNFT
Cash & Cash Equivalents
€61.6m
CAGR 3-Years
-16%
CAGR 5-Years
-26%
CAGR 10-Years
-1%
Inventiva SA
PAR:IVA
Cash & Cash Equivalents
€26.9m
CAGR 3-Years
-34%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Cash & Cash Equivalents
€89m
CAGR 3-Years
7%
CAGR 5-Years
62%
CAGR 10-Years
20%
OSE Immunotherapeutics SA
PAR:OSE
Cash & Cash Equivalents
€25.9m
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
N/A

See Also

What is Gensight Biologics SA's Cash & Cash Equivalents?
Cash & Cash Equivalents
6.9m EUR

Based on the financial report for Jun 30, 2024, Gensight Biologics SA's Cash & Cash Equivalents amounts to 6.9m EUR.

What is Gensight Biologics SA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-13%

Over the last year, the Cash & Cash Equivalents growth was 580%. The average annual Cash & Cash Equivalents growth rates for Gensight Biologics SA have been -50% over the past three years , -13% over the past five years .

Back to Top